ACE2 and malaria: The low incidence of COVID-19 in malaria-endemic nations has been attributed to angiotensin-converting enzyme 2 (ACE2), hydroxychloroquine (HCQ) and chloroquine (CQ), interferons, and neutralizing antibodies [8].